primary cell culture market size was valued at US$ 5.99 Billion in 2023 and is expected to reach US$ 13.30 Billion by 2031

BURLINGAME, CALIFORNIA , UNITED STATES, May 24, 2024 /EINPresswire.com/ -- Market Overview:

Primary cell culture refers to the direct extraction and culture of cells from tissues or organs for experimental purposes. Primary cells retain tissue-specific functions and are used in disease modeling, drug discovery, and other applications.

Market Dynamics:

The global primary cell culture market is expected to witness significant growth over the forecast period, owing to rising demand for personalized medicine and cell-based research. Primary cells can serve as functional models for specific tissues. Researchers leverage primary cells to understand disease mechanisms and for identifying new drug targets. Additionally, growing focus on developing organ-on-chip technology for drug screening and toxicity testing will further support market growth between 2024-2031. Coupled with this, favorable government funding for cell-based research is also fueling the adoption of primary cell culture in pharmaceutical and biotechnology companies.

Get an Exclusive Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/6620

Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, a detailed analysis of the competitive landscape, and product services of key players. Analysis of Global Primary Cell Culture companies, key tactics followed by Leading Key Players:

◘ Merck KGaA
◘ Thermo Fisher Scientific Inc.
◘ Danaher
◘ Lonza
◘ PromoCell GmbH
◘ Corning Incorporated
◘ FUJIFILM Irvine Scientific Inc.
◘ Mattek
◘ Axol Bioscience Ltd.
◘ ATCC
◘ QIAGEN and HiMedia Laboratories

Major Drivers

Research and Development Investments in Cell Culture Technology by Pharmaceutical Companies

The primary cell culture market is witness significant growth due to heavy investments made by leading pharmaceutical players in the research and development of cell culture technology. Cell culture finds widespread application in drug discovery, toxicology testing, and production of biologics. Pharmaceutical giants are increasingly focusing on developing novel drugs using primary cells due to their ability to mimic in vivo conditions. Furthermore, cell culture aids in reducing reliance on animal models for testing. Such benefits have prompted pharmaceutical players to invest substantial capital in building robust cell culture infrastructure and capabilities.

Rising Demand for Personalized Medicine and Regenerative Therapies

Advancements in personalized medicine and regenerative therapies are another key growth driver for the primary cell culture market. There is a growing demand for customized treatment options tailored to individual patient's genetic makeup. Primary cells are well-suited for applications involving tissue engineering, immunotherapy, and stem cell therapy due to their ability to retain characteristics of the original tissue. Furthermore, cell culture technologies are helping doctors replicate tissues and organs for repairing damage caused by diseases. The development of advanced therapies including CAR T-cell therapy has further necessitated robust primary cell culture infrastructures.

Major Restrain Hindering Market Potential

High Cost of Establishing Cell Culture Infrastructure

One of the major challenges restraining widespread adoption of primary cell culture is the high initial capital investments required for setting up cell culture laboratories and facilities. Right from procuring required equipment such as incubators, bioreactors, centrifuges to maintaining sterile facilities, advanced cell culture needs significant monetary commitments. Additional operating costs include expenses related to specialized culture media, reagents, and skilled labor. These steep costs make cell culture technology unviable for small labs and startup companies. However, with reduction in prices of key equipment and dissemination of knowledge, the constraints pertaining to costs are expected to be addressed in the coming years.

Major Opportunity for Market Expansion

Increasing Outsourcing of Cell-Based Assays

The primary cell culture market is witnessing new prospects owing to rising trend of outsourcing cell-based assays and services. Players are outsourcing activities like assay development, screening, cell line authentication, and banking to specialty contract research organizations (CROs) to better focus on their core competencies. This has opened up opportunities for CROs with cell culture capabilities to support life science research activities of biotech and pharma companies. Furthermore, the demand for primary human cells is increasing from cell therapy providers for applications such as chimeric antigen receptor T-cell therapy development. Such emerging demand streams are likely to boost outsourcing, thereby creating new avenues for contract service providers in the global primary cell culture industry.

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/6620

Key Market Trend

Growing Adoption of Automated Systems

The primary cell culture market is demonstrating a pivotal trend of shifting from traditional manual processes to automated and robotic systems. Automated platforms aid in overcoming issues of subjectivity and lack of reproducibility associated with manual methods. They ensure greater consistency and scalability of cell culture processes. Vendors are increasingly focusing on developing systems integrated with robotics, liquid handling, sensors and imaging capabilities to automate steps involving cell counting, passaging, sampling and analysis. Such systems are helping researchers scale-up cell production, thereby supporting drug discovery and clinical research. The automation trend is expected to drive efficiency and quality enhancement of primary cell-based workstreams going forward.

Segment Details Analysis

By Product Type:

Primary Cells
Instruments
Reagents and Supplements
Media
Other Consumables

By Cell Type:

Human Primary Cells
Animal Primary Cells

By Application:

Cell & Gene Therapy Development
Vaccine Production
Drug Discovery and Development
Cancer Research
Prenatal Diagnosis
Others

By End User:

Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Contract Research Organizations (CROs)
Others

The Study Objectives are:

A comprehensive insight into key players operating in the Global Primary Cell Culture Market and their corresponding data.
It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
Regional analysis, which includes insight into the dominant market and corresponding market share.
It also includes various socio-economic factors affecting the evolution of the market in the region.
The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.
Table of Contents:

Market scenario 2024

Chapter 1: Introduction, Market Driving Force Product Objective of Study and Research Scope the Global Primary Cell Culture market
Chapter 2: Exclusive Summary - the basic information of the Global Primary Cell Culture Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends, and Challenges & Opportunities of the Global Primary Cell Culture
Chapter 4: Presenting the Global Primary Cell Culture Market Factor Analysis, Supply/Value Chain, PESTEL analysis, Market Entry, and Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User, and Region/Country 2024 - 2031
Chapter 6: Evaluating the leading manufacturers of the Global Primary Cell Culture market which consists of its Competitive Landscape, Peer Group Analysis, Market positioning & Company Profile
Chapter 7: To evaluate the market by segments, by countries, and by Manufacturers/Companies with revenue share and sales by key countries in these various regions (2024-2031)
Chapters 8 & 9: Displaying the Appendix, Methodology, and Data Source

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/6620

Key Questions Answered:

What is the market size and CAGR of the Global Primary Cell Culture Market during the forecast period?
How is the growing demand impacting the growth of Global Primary Cell Culture Market shares?
What is the growing demand of the Market during the forecast period?
Who are the leading vendors in the market and what are their market shares?
What is the impact of the COVID-19 pandemic on the APAC Global Primary Cell Culture Market?

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.